How integrating strategic design with implementation expertise can help create more scalable, locally relevant, and effective global PSPs.
The US pharmaceutical industry is entering a new phase of supply chain transformation.
For GSK, ASCO 2026 was about long-term follow-up data, with new data from ongoing trials of Jemperli and Blenrep.
A half-day symposium – titled Women’s Health: From Intractable to Investable – was held in London on 11th June, organised by Weatherden.
Editor's Picks
